A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients
Public ClinicalTrials.gov record NCT03780543. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Open-label, Long-term Extension Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Open-label, extension study to evaluate the safety and efficacy of combination therapy and its effect on sustained viral response biomarkers.
Study identification
- NCT ID
- NCT03780543
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 92 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 71 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 20, 2018 (Actual)
- Primary completion
- Apr 26, 2021 (Actual)
- Completion
- Apr 26, 2021 (Actual)
- Last update posted
- Apr 19, 2023
2018 – 2021
United States locations
- U.S. sites
- 17
- U.S. states
- 6
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Beverly Hills | California | 90211 | — |
| Southern California Research Center | Coronado | California | 92118 | — |
| Coalition of Inclusive Medicine | Los Angeles | California | 90057 | — |
| University of California Los Angeles | Los Angeles | California | 90095 | — |
| Research and Education | San Diego | California | 92115 | — |
| Medical Associates Research Group | San Diego | California | 92123 | — |
| Quest Clinical Research | San Francisco | California | 94115 | — |
| Stanford University Medical Center | Stanford | California | 94305 | — |
| University of Miami Hospital and Clinics | Miami | Florida | 33136 | — |
| Johns Hopkins University School of Medicine | Baltimore | Maryland | 21287 | — |
| Digestive Disease Associates | Catonsville | Maryland | 21228 | — |
| Infectious Disease Care | Hillsborough | New Jersey | 08844 | — |
| Sing Chan, MD | Flushing | New York | 11355 | — |
| NYU Langone Health | New York | New York | 10016 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Xiaoli Ma, MD | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03780543, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03780543 live on ClinicalTrials.gov.